FDA AUTHORIZED REPORTS INCLUDED

Health + Ancestry Service

Price:$249
FDA AUTHORIZED REPORTS INCLUDED

Health + Ancestry Service

Get genetic insights into your ancestry, traits and health that can help make it easier for you to take action on your health.

  • 150+ personalized reports
  • Includes Ancestry + Traits Service

Add to cart

Price:$249
Important test info

There is a lot to consider with genetic testing. We encourage you to review relevant information about Carrier Status* and Genetic Health Risk* reports.

Important test info

Health + Ancestry Service
Add to cart
Price:$249
Add to cart

There's more than
one way
to get to
know your genes.

Our Health + Ancestry Service not only lets you discover what your DNA has to say about your health, you’ll also gain powerful insights into your ancestry and traits.

FeatureAncestry + Traits ServiceHealth + Ancestry Service

Ancestry + Traits
Service

Price:$129
Add to cart
Recommended

Health + Ancestry
Service

Price:$249
Add to cartImportant test info
Total reports80+150+
Ancestry reportsincludedincluded
Family Treeincludedincluded
DNA Relative Finder
includedincluded
Trait reports
includedincluded
Health Predisposition reports*
not includedincluded
Carrier Status reports*
not includedincluded
Wellness reports
not includedincluded
Customer Stories

Putting insights into action

As more and more people choose DNA testing for health reasons, they're sharing more and more inspiring stories. These are just a few of the stories of 23andMe customers who used what they learned from their DNA to take a more proactive approach to their health.

Watch Charlie's story

Watch Charlie's story

Uncovering a truth

Watch Kristin's story

Watch Kristin's story

Taking action

Stay in the know.

Keep up-to-date with new discoveries and exclusive promotions on our DNA test kits.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/